• Mani posted nine-month net sales of JPY 24.4 billion, up 9.5% year on year, with operating income rising 22% to JPY 7.49 billion.
• Ordinary income climbed 33.3% to JPY 8.04 billion; profit attributable to owners of parent increased 32.6% to JPY 5.64 billion.
• Dental products led growth, with segment net sales up 16.2% to JPY 8.1 billion; segment income more than doubled to JPY 1.47 billion.
• China dia-bur sales resumed in November 2025 after regulatory approval, with recovery running ahead of targets; FY2026 sales now seen at about JPY 2.1 billion.
• Full-year forecasts were raised to net sales of JPY 32.9 billion, operating income of JPY 9.7 billion, ordinary income of JPY 10.15 billion, profit of JPY 6.8 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mani Inc. published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.